T cell receptor repertoire characteristics both before and following immunotherapy correlate with clinical response in mesothelioma.
Vroman H, Balzaretti G, Belderbos RA, Klarenbeek PL, van Nimwegen M, Bezemer K, Cornelissen R, Niewold ITG, van Schaik BD, van Kampen AH, Aerts JGJV, de Vries N, Hendriks RW.
Vroman H, et al. Among authors: aerts jgjv.
J Immunother Cancer. 2020 Mar;8(1):e000251. doi: 10.1136/jitc-2019-000251.
J Immunother Cancer. 2020.
PMID: 32234848
Free PMC article.